| 产品编号 | 图片 | CAS No. | 名称及描述 | 规格 | 价格 | 分子式 | 快速订购 |
|---|---|---|---|---|---|---|---|
| GC32348-500μg |
|
219552-69-9 |
Parasin I - Glpbio |
0 | 需询价 | C82H154N34O24 | |
| GC32347-5mg |
|
136212-91-4 |
Dermaseptin - Glpbio |
0 | 需询价 | C152H257N43O44S2 | |
| GC32347-1mg |
|
136212-91-4 |
Dermaseptin - Glpbio |
0 | 需询价 | C152H257N43O44S2 | |
| GC32347-500μg |
|
136212-91-4 |
Dermaseptin - Glpbio |
0 | 需询价 | C152H257N43O44S2 | |
| GC32346-500mg |
|
79622-59-6 |
Fluazinam - Glpbio |
0 | 需询价 | C13H4Cl2F6N4O4 | |
| GC32346-100mg |
|
79622-59-6 |
Fluazinam - Glpbio |
0 | 需询价 | C13H4Cl2F6N4O4 | |
| GC32346-10mM(1mLinDMSO) |
|
79622-59-6 |
Fluazinam - Glpbio |
0 | 需询价 | C13H4Cl2F6N4O4 | |
| GC32345-100mg |
|
233254-24-5 |
Tomeglovir (BAY 38-4766) - Glpbio |
0 | 需询价 | C23H27N3O4S | |
| GC32345-50mg |
|
233254-24-5 |
Tomeglovir (BAY 38-4766) - Glpbio |
0 | 需询价 | C23H27N3O4S | |
| GC32345-25mg |
|
233254-24-5 |
Tomeglovir (BAY 38-4766) - Glpbio |
0 | 需询价 | C23H27N3O4S | |
| GC32345-10mg |
|
233254-24-5 |
Tomeglovir (BAY 38-4766) - Glpbio |
0 | 需询价 | C23H27N3O4S | |
| GC32345-5mg |
|
233254-24-5 |
Tomeglovir (BAY 38-4766) - Glpbio |
0 | 需询价 | C23H27N3O4S | |
| GC32345-10mM(1mLinDMSO) |
|
233254-24-5 |
Tomeglovir (BAY 38-4766) - Glpbio |
0 | 需询价 | C23H27N3O4S | |
| GC32344-5mg |
|
1496552-16-9 |
Sofosbuvir impurity A - Glpbio |
0 | 需询价 | C22H29FN3O9P | |
| GC32344-1mg |
|
1496552-16-9 |
Sofosbuvir impurity A - Glpbio |
0 | 需询价 | C22H29FN3O9P | |
| GC32344-10mM(1mLinDMSO) |
|
1496552-16-9 |
Sofosbuvir impurity A - Glpbio |
0 | 需询价 | C22H29FN3O9P | |
| GC32343-5g |
|
5355-16-8 |
Diaveridine (EGIS-5645) - Glpbio |
0 | 需询价 | C13H16N4O2 | |
| GC32343-1g |
|
5355-16-8 |
Diaveridine (EGIS-5645) - Glpbio |
0 | 需询价 | C13H16N4O2 | |
| GC32343-250mg |
|
5355-16-8 |
Diaveridine (EGIS-5645) - Glpbio |
0 | 需询价 | C13H16N4O2 | |
| GC32343-10mM(1mLinDMSO) |
|
5355-16-8 |
Diaveridine (EGIS-5645) - Glpbio |
0 | 需询价 | C13H16N4O2 | |
小泰
|
010-60710855
|